Anthony D. Martinez MD

Anthony Martinez

Anthony D. Martinez
MD

Clinical Associate Professor

Department of Medicine

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Addictions; Gastroenterology; HIV Human Immunodeficiency Virus; Illicit Drugs; Infectious Disease; Internal Medicine; Liver (Hepatology); Substance Use; Substance Use Disorder; Translational Research

Contact Information
462 Grider Street
Buffalo, New York 14215
Phone: 716-898-6410
Fax: 716-898-3363
adm35@buffalo.edu
View map


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD

Overview Research Publications Activities Latest News

Professional Summary:

Dr. Martinez cares for patients with liver disease and addiction disorders, including opiate dependency, viral hepatitis, alcoholic and fatty liver disease, at Erie County Medical Center where he is the medical director of hepatology. His clinic “La Bodega” has been recognized both nationally and internationally as a novel co-localized model for the management of viral hepatitis and addiction disorders and has been awarded a New York State World AIDS Day Commissioner’s Special Recognition Award. The clinic has also been designated as a center for drug user health in New York State. Dr. Martinez has lectured around the world on Hepatitis C management among people with substance use disorders, most recently at the International Hepatology Exchange in Amsterdam. His team’s work has been presented at the annual liver meeting of the American Association for the Study of Liver; the annual conference of the International Network On Viral Hepatitis in Substance Users and at the International Liver Congress.

His research involves improving hepatitis C treatment in populations disproportionately affected by HCV but with limited access to health care as well as developing novel modalities to deliver care. The goal of his research is to expand HCV treatment services to a wide-ranging group of patients, especially those without immediate access to care, in an effort to reduce global disease burden. He has been a primary and co-investigator on numerous clinical trials related to new therapeutic agents for hepatitis C and fatty liver disease.

Martinez is committed to training the next generation of medical providers and has mentored medical students, residents and fellows throughout their training. He has led the New York State hepatitis C mini residency program to aid in the clinical development of emerging hepatitis C providers in order to decentralize the management of hepatitis c in an effort to extend treatment to those who need it most.

A fierce advocate, he has worked to eliminate hepatitis C treatment restrictions throughout the United States and in Europe.

Dr. Martinez is a fellow of the American Association for the Study of Liver Disease where he was recently elected to the HCV special interest group steering committee, the European Association for the Study of The Liver and the American Society of Addiction Medicine.

Education and Training:
  • Certificate, Infectious Diseases, American Academy of HIV Medicine (2015)
  • Fellowship, Addiction Medicine, Weill Medical College, Cornell University (2007)
  • Fellowship, Hepatitis C Evaluation and Management, Weill Medical College, Cornell University (2007)
  • Internship, Internal Medicine, Boston University, Roger Williams Medical Center (2006)
  • Residency, Internal Medicine, Boston University, Roger Williams Medical Center (2006)
  • MD, Universidad Autonoma de Guadalajara (2002)
  • BS, Biology, Providence College (1998)

Employment:
  • Associate Professor, Hepatology, Erie County Medical Center (2013-present)
  • Associate Professor, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2013-present)
  • Medical Director - Hepatology, GI and Hepatology, Erie County Medical Center (2013-present)
  • Associate Professor, Behavioral Medicine, VA Western NY Healthcare (2013–2017)
  • Associate Clinical Professor of Medicine, University of California San Diego (2012–2013)
  • Attending Physician, University of California (2008–2013)
  • Clinical Assistant Professor of Medicine, University of California San Diego (2008–2012)
  • Clinical Assistant Professor of Medicine and Public Health, Weill Cornell Medical College (2007–2008)
  • Assistant Attending Physician, New York Presbyterian Hospital (2006–2007)
  • Clinical Instructor, Medicine and Public Health, Weill Cornell Medical College (2006–2007)

Awards and Honors:
  • New York State World AIDS Day Commissioner's Special Recognition Award (2023)
  • Excellence in Education (2022)
  • Excellence in Healthcare (2022)
  • Gold Humanism Honor Society (2022)
  • America's Top Doctors (2021)
  • Fellow (2020)
  • Nominee, SUNY Hispanic Leadership Institute Fellowship (2020)
  • Siegel Award For Teaching Excellence Nominee (2019)
  • New York State World AIDS Day Commissioner’s Special Recognition Award – Hepatitis C (2018)
  • America's Top Doctors (2017)
  • America's Top Doctors (2016)
  • Award To Clinical Faculty for Scholarship (2016)
  • Junior Resident of the Year (2004)
  • Intern of the Year (2003)
  • National Hispanic Society Scholar (1996)
  • National Kidney Foundation Scholar (1996)
  • Latino Dollars for Scholars Award (1994)

Research Expertise:
  • Addiction Medicine
  • Hepatology
  • HIV specialist
  • Liver disease
  • Medical Marijuana In Clinical Practice
  • Viral Hepatitis

Research Centers:
  • Clinical and Translational Research Center (CTRC)

Grants and Sponsored Research:
  • Gilead Preventative HIV/HCV/HBV Preventative Screening Grant (FOCUS)
    Gilead
    Role: Co-Investigator

Journal Articles:

Abstracts:

  • Martinez et al. (2022) Hepatitis C virus prevalence and outcomes among pregnant women who inject drugs. 10th International Conference on Health and Hepatitis Care in Substance Users. Glasgow Scottland, (Dec) Poster
  • Martinez, et al. (2022) YOUNGER AGE IS ASSOCIATED WITH LOWER TREATMENT ADHERENCE AMONG PWID TREATED FOR CHRONIC HCV INFECTION. The Liver Meeting American Association For The Study Of Liver Disease. Washington DC, Washington (Nov) Poster
  • Martinez, et al. (2022) ACTIVE DRUG USE IS NOT ASSOCIATED WITH TREATMENT FAILURE AMONG PWID PATIENTS WITH VARIABLE ADHERENCE TO HCV TREATMENT. The Liver Meeting American Association For The Study Of Liver Disease, Washington. Washington, DC, Washington (Nov) Poster
  • Martinez, et al. (2022) 34. VARIABLE ADHERENCE TO HCV TREATMENT AMONG PEOPLE WHO INJECT DRUGS TREATED WITH 8 VERSUS 12 WEEKS OF ANTIVIRAL THERAPY RESULTED IN HIGH RATES OF SVR12 AND REINFECTION RATE WAS LOW. The Liver Meeting American Association For The Study Of Liver Disease. Washington DC, (Nov) Poster
  • Martinez, et al. (2022) F3-4 HEPATIC FIBROSIS IS ASSOCIATED WITH BETTER TREATMENT ADHERENCE BUT NOT INCREASED SVR12 AMONG PWID PATIENTS TREATED FOR HCV. The Liver Meeting American Association For The Study Of Liver Disease,. Washington DC, (Nov) Poster
  • Martinez, et al. (2022) Reported safety of HCV direct-acting antivirals with opioids: 2017 to 2021. International Liver Congress, European Association for The Study of Liver. London, (May), (2990) Poster
  • (2021) SHORTER DURATION HEPATITIS C VIRUS TREATMENT IS ASSOCIATED WITH BETTER PERSISTENCE TO PRESCRIPTION FILLS IN PEOPLE WHO INJECT DRUGS. American Association For The Study Of Liver Disease, (Nov), (986) Poster
  • (2021) Good Practice Hepatitis C Screening and Linkage To Care Initiatives at the SLTC Summit 2020: Three Out of Four Diagnosed Patients Able To Start Direct-acting Antiviral Treatment. European Association for The Study of Liver, (Apr)
  • Martinez AD. (2015) Age and Risk Factor-Based Serologic Screening for Hepatitis C Virus Among an Urban High-Risk Population. The Liver Meeting, American Association For The Study of Liver Disease, (Nov)
  • Martinez AD. (2015) Utilization of Telemedicine To Treat Hepatitis C at a Medication Assisted Opioid Treatment Program. American Association for the Treatment of Opiate Dependence National Conference, (Jan)

Professional Memberships:
  • International Network on Health and Hepatitis in Substance Users (2017–present)
  • American Society for Colposcopy and Cervical Pathology (2015–2016)
  • American Academy of HIV Medicine (2014–present)
  • European Association for the Study of Liver Disease; Member (2012–present)
  • American Association for the Study of Liver Diseases; 2009-Member 2011-Member of AASLD Hepatitis C Special Interest Group (2009–present)
  • American College of Physicians; Member (2008–2012)
  • New York Society of Addiction Medicine; Member (2008–present)
  • USA Boxing, Physician Member (2007–present)
  • New York Medical Reserve Corps; Member (2006–2010)
  • Ameican Society of Addiction Medicine; Member (2006–present)
  • National Hispanic Medical Association; Member (2005–present)
See all (1 more)

Presentations:
  • "La Bodega: A Co-Localized Approach to HCV and Addiction Disorders" Tip-HepC webinar: HepC in Pregnancy: Strategies to Improve Linkage to Care and Treatment (2023)
  • "Are We On Track? An Update on the Elimination of HCV" CAHNference (2022)
  • "Co-Medication in People Who Inject Drugs," International Grand Rounds Series (2022)
  • "Headline Views in CLD and GI Disorders: HCV" Chronic Liver Disease Foundation Webcast (2022)
  • "Managing HCV: Tackling Tough Cases" CME Outfitters webcast (2022)
  • "Hepatitis C and People Who Inject Drugs" 50th Annual NAADAC Conference (2022)
  • "Hepatocellular Carcinoma in the Setting of HIV, HCV and HBV" Cancer Prevention for People Living with HIV Continuing Education Course, Erie County Medical Center (2022)
  • "The Syndemic of HCV, HIV and SUD" Division of Addiction Medicine Grand Rounds, University at Buffalo (2022)
  • "HCV For The Rheumatologist" Grand rounds - Division of Rheumatology (2022)
  • "The Syndemic of HIV, HCV and Substance Use" National Latinx Conference on HIV/HCV/SUD (2022)
  • "Treatment Decisions for Patients with HCV and CKD: CMEO Briefcase" CME Outfitters Broadcast (2022)
  • "X-Express: Buprenorphine Prescribing for Beginners Tailored For Gastroenterology and Hepatology Specialists" Clinical Education Initiative affiliated with Mt. Sinai (2022)
  • "HCV/HIV Co-Infection and The Impact of Injection Drug Use" HIV Grand Rounds (2022)
  • "Addressing HCV In Your Patients Struggling With Addiction" The 18th Annual Hepatitis C Summit, Los Angeles, CA (2021)
  • "HCV and Injection Drug Use" Clinical Education Initiative affiliated with Mt. Sinai, NY (2021)
  • "Building momentum towards HCV elimination: re-engaging patients in the COVID-era and beyond" British Columbia Liver Forum (2021)
  • "Decentralized HCV Care: A Perfect Position for Addiction Specialists" National Conference on Addiction Disorders (2021)
  • "HCV Clinical Cases Workshop" British Columbia Liver Forum (2021)
  • "Treating an Evolving Epidemic During the COVID-19 Pandemic" America’s Essential Hospitals Webinar (2021)
  • "Hepatitis C: Why Is It Relevant to Addiction Medicine?," 18th Annual Improving Outcomes In The Treatment Of Opiate Dependence (iOTOD) conference (2021)
  • "HCV Re-Infection" Clinical Education Initiative (2021)
  • "HCV 2021" Western New York Physician Assistant Association (2021)
  • "Medical Marijuana In Clinical Practice" Primary Care Update; University at Buffalo (2017)
  • "Addressing Hepatitis C – Leave No One Behind" United States Conference on AIDS (2016)
  • "HCV - No One Left Behind" 11th National Harm Reduction Conference; National Harm Reduction Organization (2016)
  • "HCV And The Active Substance User" HepCure Webinar; New York State Clinical Education Initiative (2016)
  • "HCV State of The Art" Grand Rounds; University at Buffalo; gastroenterology (2016)
  • "HCV/HIV Co-Infection" Updates In Viral Hepatitis and Hepatocellular Carcinoma Conference; University at Buffalo (2016)
  • "Hepatocellular Carcinoma Screening and Surveillance" Updates In Viral Hepatitis and Hepatocellular Carcinoma Conference; University at Buffalo (2016)
  • "Impact of a Multi-Disciplinary Approach in Disease Management of Hepatic Encephalopathy in Patients with Decompensated Cirrhosis" American College of Gastroenterology Annual Meeting; ACG (2016)
  • "Knowledge of Hepatitis C Acquisition Risks is Associated with Improved Birth Cohort-based Screening Practices among Primary Care Physicians" European Association for The Study of Liver Disease; EASL (2016)
  • "Medical Marijuana: A New Era for Chronic Disease Management in New York State" City Wide Grand Rounds; University at Buffalo (2016)
  • "The Etiology, Natural History and Bleeding Risk of Gastroesophageal Varices" Research Day; University at Buffalo (2016)
  • "Treatment for Hepatitis C: New Tests, New Drugs and New Recommendations" Clinical Education Initiative; Mt. Sinai (2016)
  • "Collaboration In Buffalo: How Liver Care Is Changing The Face of a City" HCV Next Magazine (2015)
  • "Evolving Mindsets: Addiction and Hepatitis C" Association of Nurses in AIDS Care National Meeting; Association of Nurses in AIDS Care (2015)
  • "Treatment for Hepatitis C: New Tests, New Drugs & New Recommendations" The Nurse Practitioner Association of NY State Annual Conference; Nurse Practitioner Association of NY (2015)
  • "Update On The Management of HCV" City Wide Grand Rounds; University at Buffalo (2015)
  • "HCV and Addiction Medicine" Advances in HCV 2015 Conference; University at Buffalo (2015)
  • "HCV and Addiction Medicine" Advances in HCV 2015 Conference; University at Buffalo (2015)
  • "Age and Risk Factor-Based Serologic Screening for Hepatitis C Virus Among an Urban High-Risk Population" The Liver Meeting; American Association for The Study of Liver Disease (2015)
  • "HCV Who is at risk and how can they be reached" Medpage Today interview; University at Buffalo (2015)
  • "Love Your Liver: Clinical Endeavors" Partners in Discovery Lecture Series; University at Buffalo (2015)
  • "Treatment for Hepatitis C: New Tests, New Drugs & New Recommendations" American College of Physicians District Meeting; American College of Physicians (2015)
  • "Utilization of Telemedicine To Treat Hepatitis C at a Medication Assisted Opioid Treatment Program" American Association for the Treatment of Opiate Dependence National Conference (2015)
  • "HCV Management Update" Grand Rounds; University at Buffalo; GI, Hepatology and Nutrition (2014)
  • "It’s Not Chopped Liver! Understanding The Organ and Viral Hepatitis" Mini-Med School Seminar; University at Buffalo; Public (2014)
  • "HCV Management Update" Conference on The Management of Hepatitis C Viral Infection; University at Buffalo; University at Buffalo School of Pharmacy and Biomedical Sciences (2014)
  • "Update On The Management of Hepatitis C Infection" PharmEd Conference (2014)
  • "Implementing Hepatitis C Therapy in a Primary Care Practice" Managing The Hepatitis C Patient: From Screening Through Treatment Conference; SUNY Albany (2014)
  • "Innovations In Treating Hepatitis C" Grand Rounds; Holy Cross Hospital; Medicine (2014)
  • "HCV: A New Era" City Wide Grand Rounds; ; University at Buffalo (2014)
  • "Patient-Centered Evaluation In The HIV/HCV Co-Infected Population" 9th International Conference on HIV Treatment and Prevention Adherence (2014)
  • "HCV Evaluation and Management: The Evolving Paradigm" The New Paradigm of HCV Therapy-Integration of Oral Therapies Into Basic Practices Think Tank; Harvard Medical School (2013)
  • "Viral Hepatitis, Cirrhosis and Liver Cancer: Strategies for Prevention and Control" 2nd Annual UC San Diego Hepatology Program, Clinical Update for The Comprehensive Management of Cirrhosis, Viral Hepatitis, Liver Cancer and End Stage Liver Disease; University of California San Diego (2012)
  • "Advances In The Treatment of HCV" UC San Diego Viral Hepatitis and Hepatocellular Carcinoma Symposium; UC San Diego (2011)
  • "The Integrated Addiction Medicine – Hepatology Model for HCV Management Among Opiate Dependent Individuals on Methadone Maintenance Therapy" Symposium on the Treatment of Hepatitis C Virus in Patients on Opiate Agonist Treatment; Weill Cornell University (2009)
  • "Integration of Treatment Services for Hepatitis C Positive Methadone Patients" International Harm Reduction Association Conference (2008)
  • "Hepatitis C Treatment: An Integrated Approach" American Association for the Treatment of Opiate Dependence National Conference; AATOD (2007)
  • "Model for Translational Medicine in Viral Hepatitis and Substance Abuse Treatment" 18Th International Conference on the Reduction of Drug Related Harm (2007)
See all (50 more)

Service Activities:
  • GI Division Chief search committee; GI Division Chief search committee (2023–present)
  • Committee Member - Appalachian HCV Elimination Summit; Member (2022–present)
  • One-To-One Mentor American Association for the Study of Liver Disease; Mentor (2022–present)
  • Senior Moderator- HCV Special Interest group; Senior Moderator (2022–present)
  • Ambassador - Chronic Liver Disease Foundation; Ambassador (2022–present)
  • Co-Chair Chronic Liver Disease Foundation HCV committee; Co-Chair Chronic Liver Disease Foundation HCV committee (2022)
  • ; Committee member - Alliance for Patient Access (2022–present)
  • Faculty Member - International HDV faculty panel; iHEP Hepatitis D (2021–present)
  • New York State Buprenorphine working group; Member (2021–present)
  • New York State Working Group Committee - HCV among People Who Inject Drugs; Member (2021–present)
  • Elected Member At-Large Steering Committee: Hepatitis C Special Interest Group; American Association for the Study of Liver (2020–present)
  • UB HEALS Homeless Outreach program; Faculty mentor (2019–present)
  • Faculty Member international HCV faculty group; iHEP HCV (2019–present)
  • Study to Identify Barriers to HCV Treatment among People Living with HIV (2017–present)
  • Clinical and Translational Science Award Focus Group; Member (2016–present)
  • NYSDOH AIDS Institute Clinical Education Initiative (CEI) ECHO Board; Member (2016–present)
  • University at Buffalo Addiction Initiative – Clinical Services Subcommittee; Member (2016–present)
  • NYSDOH Drug User Health Capacity Building Initiative Advisory Group; Member (2016–present)
  • Western New York PrEP Implementation Working Group; Member (2016–present)
  • Gastroenterology Fellowship Program Evaluation Committee; Member (2015–present)
  • Hpatocellular Carcinoma Service line Collaborative effort with Interventional Radiology, Oncology and Strong Memorial to develop an HCC service line utilizing telemedicine for liver transplant and surgical support. Goal to develop protocols in pathology and radiology to standardize clinical data interpretation; development of a monthly tumor board; development of a tissue bank; development of a HCC CME conference to be held at UB.; Director (2014–present)
  • Faculty and Staff Workforce Diversity committee; Committee Member (2013–present)
  • Member, Expert Panel: New York State Hepatitis C Demonstration Project, Community Health Care Association of New York State; Advisor (2013–present)
  • Faculty and Staff Workforce Diversification committee, a division of the Council of Inclusion in Medicine and Science (CIMS); Member (2013–present)
  • New York State Health Department Hepatitis C Virus Mono-Infection Clinical Guidelines Committee; Member (2013–present)
  • Center for Disease Control; Translating Research to Protect Health through Health Promotion;; Panel Member (2008)

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

462 Grider Street
Buffalo, New York 14215
Phone: 716-898-6410
Fax: 716-898-3363
adm35@buffalo.edu
View map

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD
Login to Update Your Profile